| CME-
Event Calendar
2008 PILOT™ Mini-Symposia Series
There are four programs in this series. Each one will be broadcast live from a different host institution. Earn CME credit by participating in each live and interactive PILOT™ Mini-Symposium online.
|
Program 1
Recognizing and Managing Pulmonary
Comorbidities in the Context of IPF
(1 Credit)
Broadcasting live from The Brooklyn Hospital,
Brooklyn, New York
Tuesday, September 9, 2008
NOON EDT (9 AM PDT)
Steven D. Nathan, MD, Imre Noth, MD,
and Maria L. Padilla, MD |
|
|
|
|
|
|
|
Program 4
Ask the Experts: Features of a Confident IPF Diagnosis
and Changes in Clinical Insight
(1 Credit)
Coming Soon!
|
|
Content Developed by the PILOT™ Steering Committee
Click here for PILOT™ Steering Committee
CME Information
COMMERCIAL SUPPORT ACKNOWLEDGMENT
This activity is supported by an educational grant from InterMune.
NEEDS STATEMENT/TARGET AUDIENCE
Idiopathic pulmonary fibrosis (IPF) is a debilitating and almost uniformly fatal disease. Despite recent progress, the diagnosis and management of IPF remain distinct clinical challenges. In addition, the rapid emergence of scientific evidence has prompted a reexamination of standard clinical approaches. The aim of the PILOT™ initiative is to provide a forum for the open exchange of scientific ideas that results in the timely dissemination of emerging knowledge, facilitates clinical decision making, and improves patient outcomes. This activity is intended for pulmonologists, pathologists, radiologists, and primary care physicians treating patients with IPF.
EDUCATIONAL ACTIVITY OBJECTIVES
Program 1: Recognizing and Managing Pulmonary Comorbidities in the Context of IPF
Upon completion of this activity, the participants should be able to recognize the common comorbidities of IPF and how they affect accurate diagnosis, diagnose, monitor, and manage pulmonary hypertension as a comorbidity of IPF, and describe how comorbidities have impacted recent clinical trials and how they can affect interpretation of results.
Program 2: Idiopathic Pulmonary Fibrosis: A Year In Review
Upon completion of this activity, the participants should be able to use appropriate features to obtain a differential clinical diagnosis of IPF, describe the radiologic features that contribute to an accurate diagnosis of ILD, and describe the histologic features of UIP that are consistent with IPF as well as features that are not consistent with IPF.
Program 3: Recognizing and Managing an IPF Acute Exacerbation
Upon completion of this activity, the participants should be able to describe the course of IPF and what can be done to minimize the impact of an acute exacerbation, describe the diagnosis and management of common comorbidities of IPF, and integrate the management of IPF acute exacerbations by health care professionals to provide optimal care for the patient.
Program 4: Ask the Experts: Features of a Confident IPF Diagnosis and Changes in Clinical Insight
Upon completion of this activity, the participants should be able to describe recent scientific findings and their importance to the understanding of IPF, describe recent clinical trial results and incorporate their findings into clinical management of IPF, and describe the clinical trials that will be reported in the near future and how the design of new trials has been affected by recent results.
ACCREDITATION STATEMENT
The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT STATEMENT
The France Foundation designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.
FACULTY DISCLOSURE
It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty participating in this activity will disclose to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity. Faculty disclosures will be available online.
DISCLAIMER
The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and InterMune assume no liability for the information herein.
CONTACT INFORMATION
PILOT™
The France Foundation
230 Shore Road, Suite 202
Old Lyme, Connecticut 06371
Toll Free Telephone: (866) 227-6414
Fax: (866) 227-6415
Web site: www.PILOTforIPF.org
|
